Showing results (71-80 of 116) with videos related to
Sort By:
Pageof 12
Expert Review of Molecular Diagnostics|November 5, 2015
The diagnostic and prognostic potential of plasma extracellular vesicles for cardiovascular diseaseIngrid E M Bank, Leo Timmers, Crystel M Gijsberts, et al.Atherosclerosis|September 7, 2021
Colchicine reduces extracellular vesicle NLRP3 inflammasome protein levels in chronic coronary disease: A LoDoCo2 biomarker substudyMax J M Silvis, Aernoud T L Fiolet, Tjerk S J Opstal, et al.Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|July 19, 2011
Higher efficacy of pre-hospital tirofiban with longer pre-treatment time to primary PCI: protection for the negative impact of time delayTon Heestermans, Menko-Jan de Boer, Jochem W van Werkum, et al.Atherosclerosis|May 3, 2025
Interleukin-6 modifies Lipoprotein(a) and oxidized phospholipids associated cardiovascular disease risk in a secondary prevention cohortNiekbachsh Mohammadnia, Amber van Broekhoven, Willem A Bax, et al.European Journal of Preventive Cardiology|October 31, 2024
The Effects of Colchicine on Lipoprotein(a) and Oxidized Phospholipid Associated Cardiovascular Disease RiskNiekbachsh Mohammadnia, Amber van Broekhoven, Willem A Bax, et al.Journal of Clinical Epidemiology|November 28, 2020
Text-mining in electronic healthcare records can be used as efficient tool for screening and data collection in cardiovascular trials: a multicenter validation studyWouter B van Dijk, Aernoud T L Fiolet, Ewoud Schuit, et al.Journal of Cardiac Failure|July 4, 2021
Clinical Outcome Predictions for the VerICiguaT Global Study in Subjects With Heart Failure With Reduced Ejection Fraction (VICTORIA) TrialRobert J Mentz, Hillary Mulder, Arend Mosterd, et al.European Heart Journal. Quality of Care & Clinical Outcomes|March 15, 2024
Cost-effectiveness of low-dose colchicine in patients with chronic coronary disease in The NetherlandsAernoud T L Fiolet, Willem Keusters, Johan Blokzijl, et al.European Heart Journal|March 26, 2021
Efficacy and safety of low-dose colchicine in patients with coronary disease: a systematic review and meta-analysis of randomized trialsAernoud T L Fiolet, Tjerk S J Opstal, Arend Mosterd, et al.Annals of Internal Medicine|May 29, 2023
Association of Low-Dose Colchicine With Incidence of Knee and Hip Replacements : Exploratory Analyses From a Randomized, Controlled, Double-Blind TrialMichelle W J Heijman, Aernoud T L Fiolet, Arend Mosterd, et al.Pageof 12